Table 3.
Positive Correlation between PEDF and MITF Immunoreactivities According to Positive and Negative Expression in Melanocytic Lesions (n = 51)
Diagnostic group | Sample size | PEDF, no. (%) |
MITF, no. (%) |
||
---|---|---|---|---|---|
+ | − | + | − | ||
Common melanocytic nevus | 11 | 11 (100) | 0 (0) | 11 (100) | 0 (0) |
Melanoma in situ | 11 | 11 (100) | 0 (0) | 11 (100) | 0 (0) |
Primary cutaneous melanoma | 22 | 11 (50) | 11 (50) | 20 (91) | 2 (9) |
Metastatic melanoma | 7 | 1 (14) | 6 (86) | 6 (86) | 1 (14) |
Kendall’s τB = 0.35; P = 0.0003.